Since 1969 Inter Science Institute has made many research procedures and test routinely available for clinical testing and research application. Inter Science Institute is dedicated to providing specialized Endocrinology Laboratory services to the clinician, the researcher and the patient. The C.U.R.E.® handbook covers a vast area of endocrine, gastrointestinal, pancreatic, and other related procedures.
Neuroendocrine Tumor (NETs) Diagnostic Testing
Providing continuity of service for rare Endocrinology and Gastroenterology testing since 1969
is still the hallmark of Inter Science Institute.
- 5-HIAA EDTA “purple top” plasma or Z-Plasma – NYS DOH approved
- Pancreastatin – NYS DOH approved
- Neurokinin A – NYS DOH approved
- Somatostatin
- VIP
- Serotonin
- CgA
Read more about these conclusions about ISI’s Pancreastatin assay providing valuable information for patients at high risk of recurrence and accurately detecting progression.
Diabesity Related Testing
In addition to being in the forefront of NETs testing, ISI is proud to offer a wide range of testing to provide physicians and researchers critical diagnostic and monitoring tools in the field of obesity and diabetes. Our menu includes:
Please contact us (requests@interscienceinstitute.com) if you need additional information about these tests.
5-HIAA assay is now available on plasma EDTA or (Z-tubeTM) from ISI
New test available for patients: the 5-HIAA assay is now available on plasma EDTA or (Z-tubeTM) from ISI. Click here to see the requirements.
Just added: GLP-1 Assay is now fully validated for clinical use
ISI's Latest Journal Publications are Available
To learn more about how these biomarkers are used, read the paper(s) below:
- 5-HIAA
- Neurokinin A (NKA)
- Pancreastatin
- It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine Tumors
- Pancreastatin Predicts Survival in Neuroendocrine Tumors
- Development of a Highly Sensitive and Specific Carboxy-Terminal Human Pancreastatin Assay to Monitor Neuroendocrine Tumor Behavior
- A Prospective Evaluation of the Effect of Chronic Proton Pump Inhibitor Use on Plasma Biomarker Levels in Humans
- It Is Time to Rethink Biomarkers for Surveillance of Small Bowel Neuroendocrine Tumors
- Octreotide (Sandostatin®)
- A Prospective Trial on the Effect of Body Mass Index and Sex on Plasma Octreotide Levels in Patients Undergoing Long-Term Octreotide LAR Therapy
- Effect of Octreotide LAR Dose and Weight on Octreotide Blood Levels in Patients With Neuroendocrine Tumors
- Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients
- Chromogranin A
C.U.R.E.® Catalogue
The C.U.R.E.® Catalogue lists over 150 individual assays, that can be performed on plasma/serum, urine, CSF, Saliva, and other fluids in the areas of:
- G.I. & Pancreatic Tests
- Hypertension, Corticosteroid, & Mineralocorticoid Tests
- Hypothalamic-pituitary Axis & Releasing Factor Tests
- Multi-disciplinary Tests
Pediatric & Enzyme Deficiency Tests - Reproductive Endocrinology & Gonadal
- Steroid Tests
- Thyroid Tests
Please contact ISI for the most up-to-date testing availability.
Search Individual Assays
For the Most Recent Edition of the C.U.R.E.® (Current Unique and Rare Endocrine) Catalogue please contact the Institute at: requests@interscienceinstitute.com
ISI is the leader in neuroendocrine tumors (NET's) Biomarker Testing
Updated with ICD-10 codes
Since 1969, our cutting-edge esoteric services to the medical, research, and academic communities, Inter Science Institute specializes in research and development emphasis in the area of Neuroendocrine Tumors (NET’s). The current 5th edition handbook, Neuroendocrine Tumors: A Comprehensive Guide to Diagnosis and Management, is available for download on this website or by contacting ISI at requests@interscienceinstitute.com.